Tag Archives: LGND

Top 10 Value Stocks To Watch For 2019

Wall Street is stunned after General Electric’s board of directors replaced John Flannery as chief executive with former Danaher CEO Lawrence Culp on Monday.

Flannery, who took the reins at GE in August 2017, was brought in to help turn around the struggling industrial conglomerate after a 16-year tenure by Jeff Immelt.

Though Wall Street first applauded Flannery’s move to embark on a deep dive into the company’s businesses and finances at the start of his term, the board eventually grew unsatisfied with the pace of his execution.

Culp is expected to continue the spinoff of GE’s health-care segment following a similar strategy in its railroad business.

General Electric’s shares, once a longtime favorite for an attractive dividend, have lost nearly half of their value over the past year despite management’s efforts.

Top 10 Value Stocks To Watch For 2019: Mattersight Corporation(MATR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    KEYW (NASDAQ: KEYW) and Mattersight (NASDAQ:MATR) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, dividends, analyst recommendations and risk.

  • [By Stephan Byrd]

    Mattersight (NASDAQ: MATR) and Simulations Plus (NASDAQ:SLP) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings and analyst recommendations.

  • [By Lisa Levin] Gainers
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 22.6 percent to $3.25 in pre-market trading after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    Mattersight Corporation (NASDAQ: MATR) shares rose 23.2 percent to $2.65 in pre-market trading after the company agreed to be purchased by NICE Ltd.
    Comstock Resources, Inc. (NYSE: CRK) rose 21.2 percent to $5.77 in pre-market trading after the company disclosed a deal to buy oil & gas properties in North Dakota from Arkoma, Williston Drilling for about $620 million. The company also announced withdrawal of tender offers for outstanding secured notes.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 13.7 percent to $386.00 in pre-market trading as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Quantenna Communications, Inc. (NASDAQ: QTNA) shares rose 12.6 percent to $14.70 in pre-market trading. Quantenna is expected to release Q1 results on April 30..
    BioTelemetry, Inc. (NASDAQ: BEAT) rose 11.1 percent to $37.50 in pre-market trading as the company reported stronger-than-expected earnings for its first quarter.
    Penn National Gaming, Inc. (NASDAQ: PENN) rose 10.4 percent to $29.00 in pre-market trading after reporting strong Q1 results.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) rose 9.8 percent to $250.00 in pre-market trading following upbeat Q1 profit.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares rose 9.4 percent to $10.62 in pre-market trading as the company reported upbeat results for its first quarter.
    CYS Investments, Inc. (NYSE: CYS) rose 9.1 percent to $7.22 in pre-market trading after the company agreed to be acquired by Two Harbors Investment Corp (NYSE: TWO).
    GNC Holdings, Inc. (NYSE: GNC) rose 8.3 percent to $4.18 in pre-market trading after reporting Q1 results.
    Domino's Pizza, Inc. (NYSE: DPZ) shares rose 7.6 percent to $251.2
  • [By Shane Hupp]

    Ebix (NASDAQ: EBIX) and Mattersight (NASDAQ:MATR) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, risk, earnings, analyst recommendations, dividends and valuation.

  • [By Lisa Levin]

    Shares of Mattersight Corporation (NASDAQ: MATR) got a boost, shooting up 23 percent to $2.65 after the company agreed to be purchased by NICE Ltd.

Top 10 Value Stocks To Watch For 2019: BioScrip, Inc.(BIOS)

Advisors’ Opinion:

  • [By Logan Wallace]

    BioScrip (NASDAQ: BIOS) and Chemed (NYSE:CHE) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, analyst recommendations and risk.

  • [By Shane Hupp]

    BioScrip (NASDAQ: BIOS) and Amedisys Home Health and Hospice Care (NASDAQ:AMED) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends and risk.

  • [By Shane Hupp]

    BiosCrypto (CURRENCY:BIOS) traded flat against the US dollar during the 24 hour period ending at 22:00 PM E.T. on June 14th. BiosCrypto has a total market cap of $26,890.00 and $0.00 worth of BiosCrypto was traded on exchanges in the last day. One BiosCrypto coin can now be bought for approximately $0.0013 or 0.00000017 BTC on major exchanges. In the last week, BiosCrypto has traded down 13.4% against the US dollar.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on BioScrip (BIOS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Money Morning News Team]

    BioScrip Inc. (Nasdaq: BIOS) provides at-home medical care and services across the United States.

    BIOS’s central profit opportunity is in the rapid growth of the pharmaceutical industry. The pharmaceutical market is currently worth $12 billion and is expected to grow at an annual rate of five to seven percent.

Top 10 Value Stocks To Watch For 2019: NBT Bancorp Inc.(NBTB)

Advisors’ Opinion:

  • [By Ethan Ryder]

    NBT Bancorp (NASDAQ:NBTB) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a note issued to investors on Saturday.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on NBT Bancorp (NBTB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on NBT Bancorp (NBTB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Value Stocks To Watch For 2019: WVS Financial Corp.(WVFC)

Advisors’ Opinion:

Top 10 Value Stocks To Watch For 2019: Abengoa Yield plc(ABY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    ArtByte (ABY) is a proof-of-work (PoW) coin that uses the Scrypt hashing algorithm. It was first traded on May 1st, 2014. ArtByte’s total supply is 792,537,250 coins. ArtByte’s official website is www.artbyte.me. ArtByte’s official Twitter account is @artbyteme and its Facebook page is accessible here. The Reddit community for ArtByte is /r/ArtByte and the currency’s Github account can be viewed here.

  • [By Logan Wallace]

    ArtByte (CURRENCY:ABY) traded up 10.8% against the dollar during the 1-day period ending at 20:00 PM ET on June 14th. ArtByte has a market capitalization of $3.84 million and approximately $13,004.00 worth of ArtByte was traded on exchanges in the last 24 hours. One ArtByte coin can currently be purchased for $0.0048 or 0.00000073 BTC on popular cryptocurrency exchanges including Bittrex, Cryptopia and LiteBit.eu. Over the last week, ArtByte has traded 16.9% lower against the dollar.

  • [By Logan Wallace]

    ArtByte (CURRENCY:ABY) traded down 8% against the dollar during the 1 day period ending at 17:00 PM Eastern on September 6th. During the last week, ArtByte has traded 11.3% higher against the dollar. One ArtByte coin can currently be purchased for about $0.0029 or 0.00000045 BTC on popular cryptocurrency exchanges including LiteBit.eu, Bittrex and Cryptopia. ArtByte has a total market cap of $2.31 million and approximately $4,225.00 worth of ArtByte was traded on exchanges in the last day.

Top 10 Value Stocks To Watch For 2019: Ultralife Corporation(ULBI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Polar Power (NASDAQ: POLA) and Ultralife (NASDAQ:ULBI) are both small-cap utilities companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.

Top 10 Value Stocks To Watch For 2019: Apache Corporation(APA)

Advisors’ Opinion:

  • [By Logan Wallace]

    Apache (NYSE:APA)‘s stock had its “hold” rating reaffirmed by research analysts at Stifel Nicolaus in a report released on Thursday. They presently have a $49.00 price target on the energy company’s stock. Stifel Nicolaus’ target price suggests a potential upside of 11.80% from the company’s current price.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close was Apache Corp. (NYSE: APA) which rose over 5% to $41.75. The stock’s 52-week range is $33.60 to $51.21. Volume was 4.8 million compared to the daily average volume of 4.4 million.

  • [By Matthew DiLallo]

    In addition, the company continues to find needle-moving expansion projects, having recently unveiled the development of the Permian Highway Pipeline Project. Kinder Morgan is developing the $2 billion natural gas pipeline with private equity-backed EagleClaw Midstream and Apache Corporation (NYSE:APA). It’s a follow-up to the Gulf Coast Express Pipeline (CGX), which is a $1.75 billion gas pipeline it’s building with two other midstream companies and Apache. Kinder Morgan has already started work on GCX, which should be in service by October 2019, while PHP could follow a year later if the company gives it the green light. These projects will help offset some of the growth it will lose by selling Trans Mountain.

  • [By Paul Ausick]

    Apache Corp. (NYSE: APA) dropped about 7.3% Thursday to post a new 52-week low of $34.50. Shares closed at $37.20 on Wednesday and the stock’s 52-week high is $55.23. Volume was over 11 million, about three times the daily average of around 3.9 million. The company reported quarterly results this morning, but investors were not impressed.

Top 10 Value Stocks To Watch For 2019: Beazer Homes USA, Inc.(BZH)

Advisors’ Opinion:

  • [By Shane Hupp]

    Beazer Homes USA (NYSE:BZH) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. The firm currently has $13.00 price target on the stock, down from their previous price target of $18.00.

  • [By Tyler Crowe]

    There have been some macroeconomic signs that America’s housing boom is starting to show signs of fatigue, but those figures haven’t really shown up in the earnings reports of most homebuilders. The one exception is Beazer Homes USA (NYSE:BZH). While most companies are still showing strong home sales and growing net orders, Beazer’s fiscal third-quarter results showed some cracks in its growth trajectory.

  • [By Joseph Griffin]

    Shares of Beazer Homes USA, Inc. (NYSE:BZH) dropped 5.9% during mid-day trading on Wednesday . The company traded as low as $14.95 and last traded at $15.02. Approximately 582,100 shares traded hands during trading, an increase of 3% from the average daily volume of 566,087 shares. The stock had previously closed at $15.96.

Top 10 Value Stocks To Watch For 2019: Ligand Pharmaceuticals Incorporated(LGND)

Advisors’ Opinion:

  • [By Stephan Byrd]

    New York State Common Retirement Fund raised its stake in shares of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) by 30.7% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 56,216 shares of the biotechnology company’s stock after purchasing an additional 13,219 shares during the period. New York State Common Retirement Fund owned 0.27% of Ligand Pharmaceuticals worth $9,285,000 at the end of the most recent quarter.

  • [By Jon C. Ogg]

    Ligand Pharmaceuticals Inc. (NASDAQ: LGND) was maintained as Buy at Argus, but the firm lowered its target to $150 from $200. The independent research firm noted that recent weakness offers a buying opportunity as the company is believed to be on track to post solid earnings growth over the next several years. Ligand closed up 1.5% at $119.76 on Tuesday, in a 52-week range of $98.56 to $278.62.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Ligand Pharmaceuticals (LGND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Ligand Pharmaceuticals (LGND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribers]

    Ligand Pharmaceuticals Inc  (NASDAQ:LGND)Q4 2018 Earnings Conference CallFeb. 07, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Ligand Pharmaceuticals Inc. (NASDAQ:LGND) COO Matthew W. Foehr sold 12,000 shares of the firm’s stock in a transaction that occurred on Monday, October 1st. The stock was sold at an average price of $273.88, for a total transaction of $3,286,560.00. Following the transaction, the chief operating officer now directly owns 105,388 shares of the company’s stock, valued at $28,863,665.44. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Top 10 Value Stocks To Watch For 2019: Masonite International Corporation(DOOR)

Advisors’ Opinion:

  • [By Matt Hogan]

    Masonite International Corp (NYSE: DOOR) supplies exterior and interior doors primarily to the North American residential market. There are in a great position to profit from both new construction and the repair, renovation, and remodel ("RRR") trends of a hot real estate market.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Masonite International (DOOR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Masonite International (NYSE:DOOR) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

    Edgewell Personal Care (NYSE:EPC) was upgraded by analysts at Zacks Investment Research from a sell rating to a buy rating. Zacks Investment Research currently has $63.00 target price on the stock. According to Zacks, “Edgewell Personal Care Co. manufactures and markets personal care products. The company’s brand consists of Schick(R) and Wilkinson Sword(R) men’s and women’s shaving systems and disposable razors; Edge(R) and Skintimate(R) shave preparations; Playtex(R), Stayfree(R), Carefree(R) and o.b. (R) feminine care products; Banana Boat(R) and Hawaiian Tropic(R) sun care products; Playtex(R) infant feeding, Diaper Genie(R) and gloves; Wet Ones(R) moist wipes. Edgewell Personal Care Co., formerly known as Energizer Holdings, is based in St Louis, United States. “

Top 10 High Tech Stocks For 2019

CHICAGO Michael Ferro, the former chairman of newspaper publishing chain Tronc, has agreed to sell his 25% stake in the company for $208.6 million, according to a filing made by the company with the Securities and Exchange Commission late Friday.

Ferro, who resigned last month as chairman of the company that publishes the Chicago Tribune, Baltimore Sun, New York Daily News and other newspapers, will sell his entire stake owned through his venture Merrick Media to McCormick Media, according to the filing.

The buyer is connected to the McCormick family that has owned the Tribune for much of its history, the Tribune reports. McCormick Media will pay $23 per share for more than 9 million shares. Tronc stock closed at 17.15 per share Friday, up 4.19%.

A spokeswoman for Tronc did not immediately respond to requests for comment.

Top 10 High Tech Stocks For 2019: BankUnited, Inc.(BKU)

Advisors’ Opinion:

  • [By Logan Wallace]

    Teacher Retirement System of Texas trimmed its holdings in BankUnited (NYSE:BKU) by 35.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,661 shares of the financial services provider’s stock after selling 13,097 shares during the period. Teacher Retirement System of Texas’ holdings in BankUnited were worth $946,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Joseph Griffin]

    Here are some of the media stories that may have impacted Accern Sentiment Analysis’s rankings:

    Get BankUnited alerts:

    BankUnited (BKU) Expected to Post Quarterly Sales of $277.17 Million (americanbankingnews.com) BankUnited (BKU) Insider Sells $40,630.00 in Stock (americanbankingnews.com) BankUnited (BKU) Expected to Announce Earnings of $0.79 Per Share (americanbankingnews.com) Head to Head Contrast: BankUnited (BKU) and Capitol Federal Financial (CFFN) (americanbankingnews.com)

    NYSE BKU opened at $40.62 on Wednesday. BankUnited has a 12-month low of $30.37 and a 12-month high of $43.84. The company has a debt-to-equity ratio of 1.58, a quick ratio of 0.96 and a current ratio of 0.96. The company has a market capitalization of $4.30 billion, a PE ratio of 15.33, a price-to-earnings-growth ratio of 1.39 and a beta of 1.04.

  • [By Joseph Griffin]

    BankUnited (NYSE: BKU) and Capitol Federal Financial (NASDAQ:CFFN) are both finance companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations.

Top 10 High Tech Stocks For 2019: Calamos Global Total Return Fund(CGO)

Advisors’ Opinion:

  • [By Shane Hupp]

    Cogeco Inc. (TSE:CGO) hit a new 52-week low on Monday . The stock traded as low as C$58.08 and last traded at C$58.12, with a volume of 14200 shares changing hands. The stock had previously closed at C$58.35.

Top 10 High Tech Stocks For 2019: Four Corners Property Trust, Inc.(FCPT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Four Corners Property (FCPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Four Corners Property Trust (FCPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Neuberger Berman Group LLC trimmed its position in Four Corners Property (NYSE:FCPT) by 12.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 61,299 shares of the financial services provider’s stock after selling 8,843 shares during the period. Neuberger Berman Group LLC owned 0.10% of Four Corners Property worth $1,415,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top 10 High Tech Stocks For 2019: Castle Brands, Inc.(ROX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Castle Brands (NYSEAMERICAN:ROX) was the recipient of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 6,422,984 shares, a decrease of 5.8% from the April 30th total of 6,815,151 shares. Based on an average daily volume of 169,266 shares, the short-interest ratio is presently 37.9 days. Currently, 7.2% of the company’s stock are sold short.

Top 10 High Tech Stocks For 2019: Flowers Foods, Inc.(FLO)

Advisors’ Opinion:

  • [By Shane Hupp]

    Schwab Charles Investment Management Inc. boosted its stake in shares of Flowers Foods, Inc. (NYSE:FLO) by 14.6% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 1,940,432 shares of the company’s stock after purchasing an additional 246,581 shares during the period. Schwab Charles Investment Management Inc.’s holdings in Flowers Foods were worth $42,418,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    FlorinCoin (FLO) is a proof-of-work (PoW) coin that uses the Scrypt hashing algorithm. Its genesis date was June 17th, 2013. FlorinCoin’s total supply is 144,115,914 coins. FlorinCoin’s official website is flo.cash. FlorinCoin’s official Twitter account is @FLOblockchain and its Facebook page is accessible here. The Reddit community for FlorinCoin is /r/floblockchain and the currency’s Github account can be viewed here.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Flowers Foods (FLO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 High Tech Stocks For 2019: Intrepid Potash, Inc(IPI)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Daré Bioscience, Inc. (NASDAQ: DARE) shares climbed 54.2 percent to $1.25 on news that the company entered into worldwide license agreement for Juniper Pharmaceuticals' intravaginal ring technology platform.
    Travelzoo (NASDAQ: TZOO) climbed 21.3 percent to $9.40 following strong Q1 results.
    Intrepid Potash, Inc. (NYSE: IPI) gained 16.5 percent to $4.60.
    K12 Inc. (NYSE: LRN) shares rose 11.2 percent to $15.4206 following Q3 results.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) shares rose 11 percent to $15.3289. McDermott issued a release reiterating rejection of Subsea 7's offer.
    Six Flags Entertainment Corporation (NYSE: SIX) shares gained 9.2 percent to $64.61 as the company posted a narrower-than-expected loss for its first quarter.
    Tupperware Brands Corporation (NYSE: TUP) surged 8.5 percent to $46.00 as the company posted in-line quarterly earnings.
    Carlisle Companies Incorporated (NYSE: CSL) climbed 7.5 percent to $107.22 after reporting Q1 results.
    Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 6.1 percent to $14.78. B. Riley initiated coverage on Allena Pharmaceuticals with a Buy rating.
    Texas Instruments Incorporated (NASDAQ: TXN) rose 4.6 percent to $102.90 after the company reported stronger-than-expected earnings for its first quarter on Tuesday.
    Credit Suisse Group AG (NYSE: CS) rose 4.5 percent to $17.03 following strong Q1 results.
    STMicroelectronics N.V. (NYSE: STM) rose 4.2 percent to $22.20 after reporting Q1 results.

    Check out these big penny stock gainers and losers

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Intrepid Potash (IPI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    New York State Common Retirement Fund grew its position in shares of Intrepid Potash, Inc. (NYSE:IPI) by 24.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 98,007 shares of the basic materials company’s stock after acquiring an additional 19,200 shares during the period. New York State Common Retirement Fund owned about 0.08% of Intrepid Potash worth $357,000 as of its most recent SEC filing.

  • [By Dan Caplinger]

    Stocks rebounded on Wednesday, with the Dow Jones Industrial Average climbing back from triple-digit losses early in the session to finish with a modest gain. Market participants were initially nervous because of the continued upward pressure on interest rates and their potential negative impact on the U.S. economy. But later in the day, confidence returned, and the steadfast market reversed course. Several individual stocks had much larger advances. Norfolk Southern (NYSE:NSC), Six Flags Entertainment (NYSE:SIX), and Intrepid Potash (NYSE:IPI) were among the best performers on the day. Here’s why they did so well.

  • [By Lisa Levin] Gainers
    Daré Bioscience, Inc. (NASDAQ: DARE) shares jumped 56.69 percent to close at $1.27 on Wednesday on news that the company entered into worldwide license agreement for Juniper Pharmaceuticals' intravaginal ring technology platform.
    Vicor Corporation (NASDAQ: VICR) rose 26.84 percent to close at $37.10. Vicor posted Q1 earnings of $0.10 per share on sales of $65.2 million.
    AGM Group Holdings Inc. (NASDAQ: AGMH) climbed 25.56 percent to close at $10.61.
    Travelzoo (NASDAQ: TZOO) gained 24.7 percent to close at $9.75 following strong Q1 results.
    Intrepid Potash, Inc. (NYSE: IPI) shares climbed 19.24 percent to close at $4.71.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 18.73 percent to close at $18.64.
    Genprex, Inc. (NASDAQ: GNPX) climbed 18.28 percent to close at $5.89. Genprex expanded its operations to Cambridge, Mass.
    Scorpio Tankers Inc. (NYSE: STNG) rose 13.92 percent to close at $2.70 following Q1 results.
    Rocky Brands, Inc. (NASDAQ: RCKY) shares surged 13.57 percent to close at $23.85 after reporting Q1 results.
    Resonant Inc. (NASDAQ: RESN) shares rose 12.5 percent to close at $4.14 on Wednesday.
    USANA Health Sciences, Inc. (NYSE: USNA) jumped 11.24 percent to close at $106.85 following Q1 results.
    SUPERVALU Inc. (NYSE: SVU) rose 11.16 percent to close at $16.24 after the company reported Q4 results and agreed to sell and leaseback eight distribution centers for an aggregate purchase price of $483 million.
    K12 Inc. (NYSE: LRN) shares gained 10.74 percent to close at $15.36 following Q3 results.
    Tupperware Brands Corporation (NYSE: TUP) rose 9.15 percent to close at $46.28 as the company posted in-line quarterly earnings.
    Six Flags Entertainment Corporation (NYSE: SIX) shares climbed 8.49 percent to close at $64.18 as the company posted a narrower-than-expected loss for its first quarter.
    Carlisle Companies Incorporated (NYSE: CSL) gained 8.2 percent to close at $107.94 af
  • [By Ethan Ryder]

    Hi-Crush Partners (NYSE: HCLP) and Intrepid Potash (NYSE:IPI) are both small-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, institutional ownership, profitability, analyst recommendations and valuation.

Top 10 High Tech Stocks For 2019: Ligand Pharmaceuticals Incorporated(LGND)

Advisors’ Opinion:

  • [By Todd Campbell, Keith Speights, and Brian Feroldi]

    Investing in biotech stocks can be risky because clinical trial failures can lead to eye-popping drops in share prices. Nevertheless, the potential to benefit from revolutionary new medicines can make owning biotech stocks in a diversified portfolio smart. If you’re hunting for new biotech stocks to buy, these three Motley Fool investors think you should considerLigand Pharmaceuticals (NASDAQ:LGND), Viking Therapeutics (NASDAQ:VKTX), and Amarin Corporation (NASDAQ:AMRN). Each of these companies has catalysts that could make now a good time to pick up shares.

  • [By Logan Wallace]

    Ligand Pharmaceuticals Inc. (NASDAQ:LGND) has been assigned a consensus rating of “Buy” from the nine analysts that are covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $159.00.

  • [By Stephan Byrd]

    New York State Common Retirement Fund raised its stake in shares of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) by 30.7% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 56,216 shares of the biotechnology company’s stock after purchasing an additional 13,219 shares during the period. New York State Common Retirement Fund owned 0.27% of Ligand Pharmaceuticals worth $9,285,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Ligand Pharmaceuticals (NASDAQ:LGND) announced its quarterly earnings results on Tuesday. The biotechnology company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.98, Bloomberg Earnings reports. The firm had revenue of $56.16 million during the quarter, compared to analysts’ expectations of $43.02 million. Ligand Pharmaceuticals had a net margin of 8.90% and a return on equity of 14.44%. The company’s revenue for the quarter was up 91.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.57 earnings per share. Ligand Pharmaceuticals updated its FY18 guidance to $4.85 EPS.

  • [By Logan Wallace]

    These are some of the news stories that may have effected Accern Sentiment’s scoring:

    Get Ligand Pharmaceuticals alerts:

    Ligand Pharmaceuticals (LGND) Insider Sells $1,488,722.03 in Stock (americanbankingnews.com) Geron (GERN) Q1 Loss Narrows Y/Y, Revenues Fall, Shares Down (finance.yahoo.com) Ligand Pharmaceuticals (LGND) Upgraded to A- by TheStreet (americanbankingnews.com) Ligand to Participate in Upcoming Investor Conferences (finance.yahoo.com) Ligand Pharmaceuticals Shows Rising Price Performance With Jump To 87 RS Rating (investors.com)

    A number of research firms recently issued reports on LGND. TheStreet raised Ligand Pharmaceuticals from a “c+” rating to an “a-” rating in a research report on Wednesday. HC Wainwright reissued a “buy” rating and set a $170.00 price objective on shares of Ligand Pharmaceuticals in a research report on Friday, February 2nd. Zacks Investment Research raised Ligand Pharmaceuticals from a “hold” rating to a “buy” rating and set a $171.00 price objective for the company in a research report on Wednesday, February 28th. BidaskClub cut Ligand Pharmaceuticals from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 27th. Finally, Roth Capital lifted their price objective on Ligand Pharmaceuticals from $158.00 to $171.00 and gave the company a “buy” rating in a research report on Monday, February 26th. One research analyst has rated the stock with a sell rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $161.00.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Ligand Pharmaceuticals (LGND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 High Tech Stocks For 2019: Innoviva, Inc. (INVA)

Advisors’ Opinion:

  • [By Sean Williams]

    Lastly, there’s Innoviva (NASDAQ:INVA), which isn’t a traditional drug stock, per se. Innoviva is a royalty company that’s currently reaping benefits from a group of long-lasting COPD and asthma medications that were developed in cooperation with GlaxoSmithKline (NYSE:GSK). You know these medicines today as Breo Ellipta and Anoro Ellipta, to name a few.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Innoviva (INVA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Sean Williams, Chuck Saletta, and Brian Feroldi]

    With this in mind, we asked three Motley Fool investors to name one healthcare stock that’s tops on their list for the month of June. These three mid-cap stocks made the cut: royalty drug company Innoviva (NASDAQ:INVA), mental illness treatment center operator Acadia Healthcare (NASDAQ:ACHC), and health savings account provider HealthEquity (NASDAQ:HQY).

Top 10 High Tech Stocks For 2019: Hollysys Automation Technologies Ltd.(HOLI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Hollysys Automation Technologies Ltd (NASDAQ:HOLI) has been assigned an average rating of “Hold” from the eight analysts that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation and five have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $21.44.

  • [By Rich Smith]

    China’s Hollysys Automation Technologies (NASDAQ:HOLI) stock is up 14.3% as of 11:30 a.m. EDT, after hitting a high as much as 26% above yesterday’s close earlier this morning.

  • [By Lisa Levin]

    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares were also up, gaining 24 percent to $27.3947 following Q3 results.

    Equities Trading DOWN

Top 10 High Tech Stocks For 2019: Echo Global Logistics, Inc.(ECHO)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Echo Global Logistics (NASDAQ: ECHO) and C.H. Robinson Worldwide (NASDAQ:CHRW) are both transportation companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, analyst recommendations and risk.

  • [By Ethan Ryder]

    Forward Air (NASDAQ: FWRD) and Echo Global Logistics (NASDAQ:ECHO) are both small-cap transportation companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, institutional ownership and profitability.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Echo Global Logistics (ECHO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Performing Stocks To Watch For 2018

The Q4 2016 earnings report for small cap gun stock Sturm, Ruger & Company (NYSE: RGR) is scheduled for after the market closeson Wednesday (February 22nd) amidconcerns that regulatory and election uncertainty had pulled gun demand forward.

A technical chart for Sturm, Ruger & Company shows a volatile downtrend with shares actually falling off when Trumps election eased fears about gun control:

A long term performance chart shows Sturm, Ruger & Company underperforming volatile higher flying competitors or peers like small cap gun stock American Outdoor Brands Corp (NASDAQ: AOBC), formerly Smith & Wesson Holding Corp (NASDAQ: SWHC), and electronic control device maker TASER International, Inc (NASDAQ: TASR):

Hot Performing Stocks To Watch For 2018: Chesapeake Energy Corporation(CHK)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Wednesday was Chesapeake Energy Corp.(NYSE: CHK) which rose about 3.6% to $4.18. The stocks 52-week range is $3.55 to $8.20. Volume was more or less 37 million compared to its average volume of 33.0 million.

  • [By Paul Ausick]

    Chesapeake Energy Corp. (NYSE: CHK) posted a new 52-week low of $3.76 on Monday, down about 5% from Friday’s closing price of $3.96. The stock’s 52-week high is $8.20. Volume totaled around 21 million shares, about 40% below the daily average of around 35 million. The company had no specific news.

  • [By Chris Lange]

    And Chesapeake Energy Corp. (NYSE: CHK) is expected to report its most recent quarterly results on Thursday. The consensus estimates call for $0.15 in EPS and $2.3 billion in revenue. Shares closed trading at $5.06 on Friday, in a 52-week range of $4.38 to $8.20. The consensus price target is $5.36.

  • [By Kumar Abhishek]

    Shares ofChesapeake Energy Corporation(NYSE:CHK) have been in a downtrend over the past three months, declining 25% in this period. In a bearish move,Chesapeake Energy Corporation’s 50-day and 200-day SMA’s formed a death cross afew days ago. A death cross is a strong bearish signal. However, the stock continued to climb up. Chesapeake Energy Corporation technical chart, the stock has broken out above the 20-day SMA which had provided strong resistance in the past. A breakout above the 20-day SMA resistance in spite of death cross suggests astrong bullish trend. The stock is now forming a double bottom pattern. The double bottom is a bullish trend reversal pattern, which indicates a medium term reversal in the trend. The double bottom patternwill be complete when the stock hits the previous high.

  • [By WWW.KIPLINGER.COM]

    When it comes to energy stocks to watch, Chesapeake Energy Corporation (CHK) has to be on the top of the list.

    This past quarter, CHK continued on its transition plans to reduce its heavy debt load, remake its portfolio of assets and live to see another day. And it seemed at first, CHK was doing just that. The natural gas fracker, however, was hit by some pretty bad news at the end of the quarter.

Hot Performing Stocks To Watch For 2018: Ligand Pharmaceuticals Incorporated(LGND)

Advisors’ Opinion:

  • [By Lisa Levin]

    Ligand Pharmaceuticals Inc. (NASDAQ: LGND) shares dropped 6 percent to $132.26. Deutsche Bank downgraded Ligand Pharmaceuticals from Hold to Sell.

  • [By Lisa Levin]

    In trading on Monday, healthcare shares were relative laggards, down on the day by about 0.51 percent. Meanwhile, top losers in the sector included Ligand Pharmaceuticals Inc. (NASDAQ: LGND), down 8 percent, and ImmunoGen, Inc. (NASDAQ: IMGN) down 7 percent.

  • [By Keith Speights, Sean Williams, and Cory Renauer]

    So when we asked three of our top healthcare contributors to name three of the best stocks to invest in healthcare, it’s not surprising that their responses listed companies in three different industries: medical device makerMasimo (NASDAQ:MASI), pharmacy services giant CVS Health (NYSE:CVS) and biopharmaceutical company Ligand Pharmaceuticals (NASDAQ:LGND). Here’s why these three healthcare stocks stand out as smart picks.

  • [By Keith Speights]

    Research and development is the lifeblood of biotech companies. The potential for new drugs also serves as a primary factor driving biotech stocks higher and higher. That’s been the case for Celgene (NASDAQ:CELG), Ionis Pharmaceuticals (NASDAQ:IONS), and Ligand Pharmaceuticals (NASDAQ:LGND).

Hot Performing Stocks To Watch For 2018: Eiffage SA (EFGSY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Atlantia (ATASF) (AT.IM), Eiffage (OTCPK:EFGSY) (FGR.FP), Ferrovial (OTC:FRRVF) (FER.SM), Albertis (OTC:ABFOF) (ABE.SM) and Vinci (OTCPK:VCISF) (DG.FP)

Hot Performing Stocks To Watch For 2018: (SMPQY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    We believe that two main risks currently exist. First, a few days ago, U.S. Department of Justice filed charges in generic drug price-fixing probe. The U.S. Department of Justice accused two former generic pharmaceutical executives of colluding with other generic manufacturers to fix prices – the first criminal charges stemming from a two-year investigation. Companies in the congressional probe have since publicly disclosed that they have received subpoenas, including Mylan NV (NASDAQ:MYL), Allergan (NYSE:AGN), which later sold its generics business to Teva (NASDAQ:TEVA), Lannett (NYSEMKT:LCI), Impax Laboratories (NASDAQ:IPXL), Endo International (NASDAQ

how to invest money

BloombergBusinessweek recently had an odd story entitled: Why Did a Chinese Peroxide Company Pay $1 Billion for a Talking Cat? Inside the strange courtship between industrial behemoths and Western video game studios. The talking cat in question is Talking Tom Cat – a childrens game developed by a Slovenian couple (Samo and Iza Login they had legally changed their surname to sound techie) where an animated cat repeats in a high-pitched helium squeak whatever is spoken into an iPhones microphone. BloombergBusinessweek noted:

Talking Tom Catwas an instant hit, launching a franchise whose titles have reached No.1 in more than 100countries on the App Store. Today, almost 350million monthly active users support the apps, and Toms YouTube channel has more than 2billion views. Unlike many mobile app creators, the Logins have proved adept at turning popularity into profit. PlayingTalking Tomtriggers an onslaught of advertising and in-game purchase offers, and Outfit7 earns more than $100million a year.

how to invest money: Ligand Pharmaceuticals Incorporated(LGND)

Advisors’ Opinion:

  • [By Keith Speights]

    Research and development is the lifeblood of biotech companies. The potential for new drugs also serves as a primary factor driving biotech stocks higher and higher. That’s been the case for Celgene (NASDAQ:CELG), Ionis Pharmaceuticals (NASDAQ:IONS), and Ligand Pharmaceuticals (NASDAQ:LGND).

  • [By Keith Speights, Sean Williams, and Cory Renauer]

    So when we asked three of our top healthcare contributors to name three of the best stocks to invest in healthcare, it’s not surprising that their responses listed companies in three different industries: medical device makerMasimo (NASDAQ:MASI), pharmacy services giant CVS Health (NYSE:CVS) and biopharmaceutical company Ligand Pharmaceuticals (NASDAQ:LGND). Here’s why these three healthcare stocks stand out as smart picks.

  • [By Lisa Levin]

    Ligand Pharmaceuticals Inc. (NASDAQ: LGND) shares dropped 6 percent to $132.26. Deutsche Bank downgraded Ligand Pharmaceuticals from Hold to Sell.

how to invest money: Volkswagen Aktiengesellschaft (VLKAY)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Volkswagen AG (VLKAY) shares were under pressure Wednesday after prosecutors searched the headquarters of its Audi Group division as part of an ongoing probe into the use of ‘cheat devices’ in diesel emissions engines.

  • [By SEEKINGALPHA.COM]

    Welcome to the July 2017 edition of Electric Vehicle (EV) company news. In many ways, I think July 2017 will be remembered as a major turning point in EV history – with Model 3 production underway, the British and French governments declaring ICE bans, Volkswagen (OTCPK:VLKAY), Big Oil and the IMF acknowledging EVs are the way of the future. What a monumental month for EVs – matched with near-record global sales.

  • [By John Rosevear]

    In terms of production, Audi’s electric-vehicle effort is supported by corporate parent Volkswagens (NASDAQOTH:VLKAY) aggressive, big-budget move toward electric vehicles. Nearly all of VW’s brands are known to have long-range electric vehicles under development. Audi’s economies of scale (via VW) could well eclipse Tesla’s by early next decade.

  • [By SEEKINGALPHA.COM]

    Apart from the locals, the global competitors have also made some quick moves to make their presence felt in China. According to Reuters, Volkswagen (OTCPK:VLKAY) has recently signed a preliminary deal to set up a joint venture with China-based Anhui Jianghuai Automobile (JAC) for making electric vehicles. However, the deal has enough hurdles in its path. Also, Daimler (OTCPK:DDAIY) (OTCPK:DDAIF) is also readying some electric cars for China under the Mercedes-Benz brand.

  • [By WWW.THESTREET.COM]

    An ongoing proliferation of probes into the auto industry participants means that the practice of emissions-rigging is no longer synonymous with Germany’s Volkswagen (VLKAY) , who was the first to be rumbled in a scandal that eventually cost the world’s largest car maker more than $20 billion.

  • [By SEEKINGALPHA.COM]

    There’s a reason that it only works in one city, and on one car brand – for now. This is the kind of resource problem that is a lot easier to solve with a huge budget. That would be 10 years of a Volkswagen (OTCPK:VLKAY)-Audi $15 billion a year R&D budget, not a year’s worth of a Tesla $834 million R&D budget.

how to invest money: Monsanto Company(MON)

Advisors’ Opinion:

  • [By Chris Lange]

    Monsanto Co.’s (NYSE: MON) latest quarterly earnings report is expected on Wednesday. The consensus analyst estimates are $1.77 in earnings per share (EPS) and $4.17 billion in revenue. Shares closed trading most recently at $117.02, in a 52-week range of $97.35 to $118.15. The consensus price target is $122.66.

  • [By Shanthi Rexaline]

    Agri-Input Companies — Seeds/ Fertilizers/Pesticides Manufacturers

    Monsanto Company (NYSE: MON): +68.82 percent since 2011. Syngenta AG (ADR) (NYSE: SYT): +56.26 percent since 2011. Mosaic Co (NYSE: MOS): -63.1 percent since 2011. Potash Corporation of Saskatchewan (USA) (NYSE: POT): -67.8 percent since 2011. CF Industries Holdings, Inc. (NYSE: CF): +5.04 percent since 2011. Agrium Inc. (USA) (NYSE: AGU): +1.10 percent since 2011.

    Agri-Finance Companies

  • [By Maxx Chatsko]

    BeforeBayer(NASDAQOTH: BAYRY)arrived onto the scene, I viewedMonsanto(NYSE: MON)as an intriguing growth stock. It has a rich history of delivering value to shareholders and continues to hold a dominant technological edge over key competitors in crop protection products, seeds, and traits. While little has changed its promising pipeline and portfolio, the pending acquisition throws a wrench in anyone’s plans to start or add to a position. Uncertainty stemming from the merger provides several terrible reasons to buy Monsanto at this time.

how to invest money: Coca-Cola Bottling Co. Consolidated(COKE)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    Coca-Cola Bottling Co. (NYSE: COKE) had a revenue increase to $2.3 billion in its most recentfiscal year, from $1.7 billion in the previous one. It is moving into Ohio, Indiana, Kentucky, Illinois and West Virginia, which almost certainly will require capital. Its net sales rose 37% in the most recent quarter to $840 million. Management stated this was because of “Organic growth in the legacy territories as well as territory expansion through the acquisition of several new distribution territories from Coca-Cola led to the solid performance.” The current dividend is $1, or 0.66%.

how to invest money: Lannett Co Inc(LCI)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap generic pharmaceutical stock Lannett Company, Inc (NYSE: LCI) is thethird most shorted stock on the NYSE with short interest of 52.86% according toHighshortinterest.com.Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications and therapeutic areas. The Company believe that its ability to select viable products for development, efficiently develop such products (including obtaining any applicable regulatory approvals), vertically integrateitself into certain specialty markets and achieve economies in production are all critical for its success in the generic pharmaceutical industry in which it operates.

  • [By Lisa Levin]

    Breaking news

    Edwards Lifesciences Corp (NYSE: EW) announced plans to buy Valtech Cardio for $340 million in cash and stock. The company also announced a $1 billion buyback plan.
    Epizyme Inc (NASDAQ: EPZM) disclosed that it has received Fast Track designation for tazemetostat.
    Athene Holding Ltd. (NYSE: ATH) reported that it has priced its 23.8 million share IPO between $38 per share and $42 per share.
    Lannett Company, Inc. (NYSE: LCI) reported the approval for its Metaxalone Tablets USP, 800 mg.

  • [By Ashley Moore]

    We’ve compiled a list of the most heavily shorted stocks to show you which stocks have the most negative sentiment on the market…

    Company Name (Ticker)Short FloatShare PriceHanwha Q Cells Co. Ltd. (Nasdaq ADR: HQCL)98.52%$ 8.88Renren Inc. (NYSE: RENN)91.59%$ 8.53Weight Watchers International Inc. (NYSE: WTW)67.92%$12.57INSYS Therapeutics Inc. (Nasdaq: INSY)66.71%$10.74Twilio Inc. (NYSE: TWLO)66.34%$33.17Nutanix Inc. (Nasdaq: NTNX)65.65%$31.96Fitbit Inc. (NYSE: FIT)55.15%$ 6.06Weibo Corp. (Nasdaq ADR: WB)53.83%$55.26RPC Inc. (NYSE: RES)53.62%$21.19Straight Path Communications Inc. (NYSEMKT: STRP)49.27%$34.79Momo Inc. (Nasdaq ADR: MOMO)48.63%$26.80Seritage Growth Properties (NYSE: SRG)46.91%$44.87Lannett Company Inc. (NYSE: LCI)45.46%$23.00Gogo Inc. (Nasdaq: GOGO)43.98%$ 9.10Altisource Portfolio Solutions SA (Nasdaq: ASPS)42.78%$22.73Cheetah Mobile Inc. (NYSE ADR: CMCM)40.86%$10.00

    Some investors think the only way to profit from the stock market is to buy stocks and wait for the price to rise. However, these investors are missing out on the massive profit opportunity that comes from shorting stocks.

how to invest money: Silver Bay Realty Trust Corp.(SBY)

Advisors’ Opinion:

  • [By Mark Holder]

    Instead of competing in one-off auctions, the traditional method of acquiring homes and the one preferred by Silver Bay Realty Trust (NYSE: SBY  ) (NYSE: SBY  ) (NYSE: SBY  ) and American Homes 4 Rent (NYSE: AMH  ) (NYSE: AMH  ) (NYSE: AMH  ) , the company is obtaining non-performing loans in pools that include thousands of loans. The ultimate outcome of these different models is unknown, but the market hasso far supported Altisource Residential.

  • [By Lisa Levin]

    Shares of Silver Bay Realty Trust Corp (NYSE: SBY) got a boost, shooting up 18 percent to $21.47. Tricon Capital Group Inc. announced plans to buy Silver Bay Realty Trust for $21.50 per share.

Top 5 Heal Care Stocks To Watch Right Now

You know the old saying about how tough situations can be an acid test of character? The same goes for the character and quality of investment advisers. When volatility heightens or the markets experience sharp corrections, some advisers avoid picking up the phone. And often, when anxious clients call in with a desire to sell out of the market, many advisers and brokers have been known to capitulateagainst their better judgment.

See Also: How to Pick a Financial Planner

This raises the question: Why are you working with an investment adviser? For many, getting professional guidance in preparing for difficult markets is near the top of their priorities.

Here’s what your adviser should be doing in today’s skittish investment climate:

Reaching out to you proactively to provide emotional support Serving as a filter for information that’s useful and relevant to your needs Helping you to maintain your focus as a long-term investor

If your adviser is addressing all three during the market turmoil we’ve experienced lately, you’ll worry less, find it easier to stick to your long-term planand be more likely to achieve the financial goals your plan strives for.

Top 5 Heal Care Stocks To Watch Right Now: CVR Energy Inc.(CVI)

Advisors’ Opinion:

  • [By Robert Rapier]

    CVR Partners’ fertilizer plant is located in Coffeyville, Kansas, adjacent to the refinery owned by CVR Refining (NYSE: CVRR). CVR Energy (NYSE: CVI), majority-owned by Carl Icahn via Icahn Enterprises (NYSE: IEP), is the general partner and owns most of the units for both CVR Partners and CVR Refining.

  • [By elliottwave]

    CVR Energy, Inc. (NYSE: CVI) is currently correcting the bullish 5 waves cycle from November 2016 low as a triple three structure reaching equal legs area $20.48 – $19.56 . The move can extend lower toward the 50-61.8 percent Fibonacci area ( $18.98 – $17.34 ) as a double three but will remain supported as the stock is still looking for a move higher toward at least $31 to finish 3 waves correcting 2014 cycle. If the stock fails to make new highs after bouncing from the current inflection area , then the pullback can extend lower against $12.03 low which should hold to allow CVI to the resume higher later on

Top 5 Heal Care Stocks To Watch Right Now: Ligand Pharmaceuticals Incorporated(LGND)

Advisors’ Opinion:

  • [By Lisa Levin]

    Ligand Pharmaceuticals Inc. (NASDAQ: LGND) shares dropped 6 percent to $132.26. Deutsche Bank downgraded Ligand Pharmaceuticals from Hold to Sell.

  • [By Keith Speights, Sean Williams, and Cory Renauer]

    So when we asked three of our top healthcare contributors to name three of the best stocks to invest in healthcare, it’s not surprising that their responses listed companies in three different industries: medical device makerMasimo (NASDAQ:MASI), pharmacy services giant CVS Health (NYSE:CVS) and biopharmaceutical company Ligand Pharmaceuticals (NASDAQ:LGND). Here’s why these three healthcare stocks stand out as smart picks.

  • [By Lisa Levin]

    In trading on Monday, healthcare shares were relative laggards, down on the day by about 0.51 percent. Meanwhile, top losers in the sector included Ligand Pharmaceuticals Inc. (NASDAQ: LGND), down 8 percent, and ImmunoGen, Inc. (NASDAQ: IMGN) down 7 percent.

  • [By Keith Speights]

    Research and development is the lifeblood of biotech companies. The potential for new drugs also serves as a primary factor driving biotech stocks higher and higher. That’s been the case for Celgene (NASDAQ:CELG), Ionis Pharmaceuticals (NASDAQ:IONS), and Ligand Pharmaceuticals (NASDAQ:LGND).

Top 5 Heal Care Stocks To Watch Right Now: Alimera Sciences, Inc.(ALIM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Alimera Sciences Inc (NASDAQ: ALIM) shares shot up 59 percent to $1.69 after the company reported preliminary Q2 revenue. Alimera Sciences announced preliminary revenue of $9.3 million to $9.5 million.

  • [By Lisa Levin]

    On Thursday, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Alimera Sciences Inc (NASDAQ: ALIM) and Anthera Pharmaceuticals Inc (NASDAQ: ANTH).

Top 5 Heal Care Stocks To Watch Right Now: Triple-S Management Corporation(GTS)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap Triple-S Management Corp (NYSE: GTS) is an independent licensee of the Blue Cross Blue Shield Association. It is one of the leading players in the managed care industry in Puerto Rico. Triple-S Management has the exclusive right to use the Blue Cross Blue Shield name and mark throughout Puerto Rico, the U.S. Virgin Islands, and Costa Rica. With more than 50 years of experience in the industry, Triple-S Management offers a broad portfolio of managed care and related products in the Commercial, Medicare Advantage, and Medicaid markets under the Blue Cross Blue Shield marks. It also provides non-Blue Cross Blue Shield branded life and property and casualty insurance in Puerto Rico.

Top 5 Heal Care Stocks To Watch Right Now: Roper Technologies, Inc.(ROP)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Flexing the barbell strategy to balance Safe Havens with more cyclical exposures. In our view, industrials investors should be positioning their portfolio with a barbell strategy, with half of the exposure in Safe Havens like General Electric, Xylem (XYL), Danaher, Honeywell International, Roper Technologies (ROP), and AMETEK (AME), and the other half selectively in the cyclical names that are better positioned today, such as Pentair, HD Supply Holdings (HDS),Actuant (ATU), Atkore International Group (ATKR), Ingersoll-Rand, and Eaton (ETN). We still believe risk-reward is mostly balanced and that the macro will remain choppy into 2017, supporting a positioning in the defensive names. But if investor sentiment improves on not-worse news and earnings results, the more cyclical names could fare better.

  • [By Monica Gerson]

    Roper Technologies Inc (NYSE: ROP) is projected to report its quarterly earnings at $1.46 per share on revenue of $895.87 million.

    Express Scripts Holding Company (NASDAQ: ESRX) is expected to post its quarterly earnings at $1.22 per share on revenue of $25.20 billion.

  • [By Ben Levisohn]

    Aside from Outperform-rated Roper Technologies (ROP) SaaS platforms, which account for over +50% of earnings today, GEs Digital business strategy is the most ambitious ramp within the industrials sector. GE has made a bold bet on its game-changing Predix operating system for the Industrial IoT, which was launched in Feb-2016

  • [By Monica Gerson]

    Analysts are expecting Roper Technologies Inc (NYSE: ROP) to have earned $1.46 per share on revenue of $895.87 million in the latest quarter. Roper Technologies shares declined 0.05 percent to close at $178.63 on Friday.